Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsRob Davis is recorded as CFO at Merck & Co., Inc. (MRK). Rob Davis has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Merck & Co., Inc. on August 4, 2026. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.
“I remain very pleased with the substantial progress we're making across our business, driven by strong execution, growing contributions from new product launches, and the continued advancement of the next wave of innovation from our pipeline.”
“You know, if you look at where we're at, it's already been a very eventful year for us so far, and I would say our transformation is well underway.”
“Advancing and delivering breakthrough science to address unmet medical needs remains the foundation of our strategy to create sustainable value for patients and shareholders.”
“Our company's purpose to save and improve lives guides everything we do. In 2025, we advanced key programs across all phases of development, furthering our mission to deliver transformative medicines and vaccines that will improve health outcomes for patients around the world.”
“Our company made strong progress to start the year, with increasing contributions from our newer commercialized medicines and vaccines and continued advancement of our pipeline.”
Drug Manufacturers - General · Healthcare
CFO
